Abstract:Background & Aims: Regulatory T-cells (Tregs) impair cancer immunosurveillance by creating an immunosuppressive envi-ronment that fosters tumor cell survival. Our previous findings demonstrated that neutrophil extracellular traps (NETs), which are involved both in innate and adaptive immunity, are abundant in livers affected by non-alcoholic steatohepatitis (NASH). However, how NETs interact with Tregs in the development of NASH-associated hepatocellular carcinoma (NASH-HCC) is not known. Methods: A choline-deficient, high-fat diet+diethylnitrosamine mouse model and the stelic animal model were utilized for NASH-HCC and a western diet mouse model was used for NASH development. Treg depletion was achieved using FoxP3-DTR mice. RNA sequencing was used to explore the mechanism by which NETs could regulate Treg differentiation. Bioenergetic analyses of naive CD4+ T-cells were assessed by Seahorse. Results: Although the absolute number of CD4+ T-cells is lower in NASH livers, the Treg subpopulation is selectively increased. Depleting Tregs dramatically inhibits HCC initiation and pro-gression in NASH. There is a positive correlation between increased NET and hepatic Treg levels. RNA sequencing data re-veals that NETs impact gene expression profiles in naive CD4+ T -cells, with the most differentially expressed genes being those involved in mitochondrial oxidative phosphorylation. By facili-tating mitochondrial respiration, NETs can promote Treg differ-entiation. Metabolic reprogramming of naive CD4+ T-cells by NETs requires toll-like receptor 4. Blockade of NETs in vivo using Pad4-/-mice or DNase I treatment reduces the activity of Tregs. Conclusions: Tregs can suppress immunosurveillance in the premalignant stages of NASH. NETs facilitate the crosstalk be-tween innate and adaptive immunity in NASH by promoting Treg activity through metabolic reprogramming. Therapies targeting NETs and Treg interactions could offer a potential strategy for preventing HCC in patients with NASH. Lay summary: Regulatory T-cells (Tregs) can promote tumor development by suppressing cancer immunosurveillance, but their role in carcinogenesis during non-alcoholic steatohepatitis (NASH) progression is unknown. Herein, we discovered that selectively increased intrahepatic Tregs can promote an immu-nosuppressive environment in NASH livers. Neutrophil extra -cellular traps (NETs) link innate and adaptive immunity by promoting Treg differentiation via metabolic reprogramming of naive CD4+ T-cells. This mechanism could be targeted to prevent liver cancer in patients with NASH. (c) 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.

Neuregulin 4 Suppresses NASH-HCC Development by Restraining Tumor-Prone Liver Microenvironment

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma.

The Role of Neutrophil Extracellular Traps in Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma

Hepatic Regulatory T-cells Promote Colorectal Liver Metastasis in NASH

Regulatory T-cell and Neutrophil Extracellular Trap Interaction Contributes to Carcinogenesis in Non-Alcoholic Steatohepatitis.

Abstract 2869: The role of regulatory T cells in NASH-mediated HCC development

Targeted Inhibition of LPL/FABP4/CPT1 Fatty Acid Metabolic Axis Can Effectively Prevent the Progression of Nonalcoholic Steatohepatitis to Liver Cancer.

Mutations of NRG4 Contribute to the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Related Metabolic Disorders

ZNT1 and Zn 2+ control TLR4 and PD-L1 endocytosis in macrophages to improve chemotherapy efficacy against liver tumor

ER-residential Nogo-B Accelerates NAFLD-associated HCC Mediated by Metabolic Reprogramming of Oxldl Lipophagy.

Hepatocyte Nuclear Factor 4 Alpha Suppresses the Development of Hepatocellular Carcinoma

Role of Hepatocyte Nuclear Factor 4α in Regulating Hepatic Differentiation and the Inflammatory Response in HCC

LINC00844 Promotes Proliferation and Migration of Hepatocellular Carcinoma by Regulating NDRG1 Expression

578-P: A Loss-of-Function Mutation of NRG4 Contributes to the Pathogenesis of NAFLD and Insulin Resistance

Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice

Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer

Long Non-Coding RNA NEAT1-modulated Abnormal Lipolysis Via ATGL Drives Hepatocellular Carcinoma Proliferation.

Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulation

Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis

Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma

Hepatocyte Nuclear Factor-4Α Reverses Malignancy of Hepatocellular Carcinoma Through Regulating Mir-134 in the DLK1-DIO3 Region.